Literature DB >> 22365171

Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the "5B" approach.

Claudio Ronco1, Manish Kaushik, Roberto Valle, Nadia Aspromonte, W Frank Peacock.   

Abstract

Cardio-Renal syndrome may occur as a result of either primarily renal or cardiac dysfunction. This complex interaction requires a tailored approach to manage the underlying pathophysiology while optimizing the patient's symptoms and thus providing the best outcomes. Patients often are admitted to the hospital for signs and symptoms of congestion and fluid overload is the most frequent cause of subsequent re-admission. Fluid management is of paramount importance in the strategy of treatment for heart failure patients. Adequate fluid status should be obtained but a target value should be set according to objective indicators and biomarkers. Once the fluid excess is identified, a careful prescription of fluid removal by diuretics or extracorporeal therapies must be made. While delivering these therapies, adequate monitoring should be performed to prevent unwanted effects such as worsening of renal function or other complications. There is a very narrow window of optimal hydration for heart failure patients. Overhydration can result in myocardial stretching and potential decompensation. Inappropriate dehydration or relative reduction of circulating blood volume may result in distant organ damage caused by inadequate perfusion. We suggest consideration of the "5B" approach. This stands for balance of fluids (reflected by body weight), blood pressure, biomarkers, bioimpedance vector analysis, and blood volume. Addressing these parameters ensures that the most important issues affecting symptoms and outcomes are addressed. Furthermore, the patient is receiving the best possible care while avoiding unwanted side effects of the treatment.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365171     DOI: 10.1016/j.semnephrol.2011.11.016

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  20 in total

Review 1.  Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.

Authors:  Raj Munshi; Joseph T Flynn
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

2.  A Randomized Crossover Trial of Dietary Sodium Restriction in Stage 3-4 CKD.

Authors:  Rajiv Saran; Robin L Padilla; Brenda W Gillespie; Michael Heung; Scott L Hummel; Vimal Kumar Derebail; Bertram Pitt; Nathan W Levin; Fansan Zhu; Samer R Abbas; Li Liu; Peter Kotanko; Philip Klemmer
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-16       Impact factor: 8.237

Review 3.  Renal replacement therapy in acute kidney injury: controversy and consensus.

Authors:  Claudio Ronco; Zaccaria Ricci; Daniel De Backer; John A Kellum; Fabio S Taccone; Michael Joannidis; Peter Pickkers; Vincenzo Cantaluppi; Franco Turani; Patrick Saudan; Rinaldo Bellomo; Olivier Joannes-Boyau; Massimo Antonelli; Didier Payen; John R Prowle; Jean-Louis Vincent
Journal:  Crit Care       Date:  2015-04-06       Impact factor: 9.097

4.  Use of Multifrequency Bioimpedance Analysis in Male Patients with Acute Kidney Injury Who Are Undergoing Continuous Veno-Venous Hemodiafiltration.

Authors:  Harin Rhee; Keum Sook Jang; Min Ji Shin; Jang Won Lee; Il Young Kim; Sang Heon Song; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Eun Young Seong
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

5.  Seasonal variations in mortality and clinical indicators in international hemodialysis populations from the MONDO registry.

Authors:  Adrian M Guinsburg; Len A Usvyat; Michael Etter; Xiaoqi Xu; Stephan Thijssen; Daniele Marcelli; Bernard Canaud; Cristina Marelli; Claudia Barth; Yuedong Wang; Paola Carioni; Frank M van der Sande; Peter Kotanko; Jeroen P Kooman
Journal:  BMC Nephrol       Date:  2015-08-14       Impact factor: 2.388

6.  Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuretic peptide measurement.

Authors:  Haiyan Chen; Buyun Wu; Dehua Gong; Zhihong Liu
Journal:  Crit Care       Date:  2015-04-02       Impact factor: 9.097

Review 7.  Should we overcome the resistance to bioelectrical impedance in heart failure?

Authors:  Stephen J Hankinson; Charles H Williams; Van-Khue Ton; Stephen S Gottlieb; Charles C Hong
Journal:  Expert Rev Med Devices       Date:  2020-07-13       Impact factor: 3.166

8.  Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation.

Authors:  Sarah L Jones; Aiko Tanaka; Glenn M Eastwood; Helen Young; Leah Peck; Rinaldo Bellomo; Johan Mårtensson
Journal:  Crit Care       Date:  2015-08-12       Impact factor: 9.097

9.  Pre-operative assessment and post-operative care in elective shoulder surgery.

Authors:  Ahsan Akhtar; Robert J Macfarlane; Mohammad Waseem
Journal:  Open Orthop J       Date:  2013-09-06

10.  Olmesartan medoxomil reverses glomerulosclerosis in renal tissue induced by myocardial infarction without changes in renal function.

Authors:  Xiao-Mei Lu; Yu-Nan Jin; Ling Ma
Journal:  Exp Ther Med       Date:  2014-04-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.